Periodontal disease involves in inflammation of tissues which support the teeth, and in primarily caused by the accumulating bacterial plaque on the teeth. The extraction of teeth is the end stage. Current statistics show that about 60 % of young adults and 80 % of adults in the U
Periodontal disease is caused by bacterial plaque (emphasis on bacteria) which accumulates and adheres to the teeth. The disease results in local immunopathologic destruction of connective tissues and the bacterial antigens penetrate the periodontal tissues and initiate an inflammatory state . Gingival bleeding occurs. Ultimately, there is destruction of alveolar bone , the periodontal ligament, or a loss of support for the teeth. The extraction of teeth is the end stage . Periodontal disease is no longer considered to be a disease of just the aging population, but rather the destruction caused by bacterial plaque regardless of age .
Prophylaxis consists of good oral hygiene , and treatment has been with anti-microbial mouth washes, for example with chlorohexidine.
Other clinical diseases and certain commonly used drugs may intensify periodontal disease with CoQ10 is based upon restoration of the immune system , and is superior to anti-microbial therapy, a critique of this new therapy with CoQ10 , based on intrinsic biochemistry and the immune system, is timely. (p<0.01) and unexpectedly, the periodontal pocket depth decreased (p<0.05). All eight patients had been considered candidates for surgical intervention.
The healing was so excellent, 5-7 days post-biopsy, that the biopsy sites were difficult to locate. It was concluded that the healing was extraordinarily effective. The mean value of the specific activities of the succinate dehydrogenase-CoQ10-reductase of the gingival biopsies had increased (p<0.05) during the therapy, and which appeared to correlate with the extraordinary healing. Wilkinson and Arnold concluded that treatment of periodontitis with CoQ10 should be considered as adjunctive therapy in ordinary dental practice.
Early Research with Coenzyme Q10
In due time, CoQ10 became available in larger quantities to clinical support studies on periodontal disease. In 1971, Littarru et al. 8) reported that gingival biopsies from 13 patients, 18-62 years, and having from minor to severe periodontal disease, revealed a deficiency of CoQ10 in contrast to biopsies of normal periodontal tissue which showed no deficiency. Nakamura et al., in 197312), in cooperation with Dr. Wilkinson, a practicing dentist, determined the activities of the succinate dehydrogenase-CoQ10 reductase. The corresponding data from 15 individuals as controls, who did not have periodontal disease in comparison to levels of controls (0.001<p<0.01).
These data justified continuing clinical studies on the administration of CoQ10 to patients with periodontal disease. Nakamura et al.12) reported that about 60 % of diseased gingival tissues from 40 patients with periodontal disease showed a deficiency of CoQ10 at its site in the succinate-CoQ10 enzyme. Of 24 control biopsies from individuals who did not have periodontal disease, 20 % showed deficiencies of CoQ10. However, as a group, the tissues from the control individuals showed a negligible deficiency of CoQ10.
The deficiency of CoQ10 at the succinate site of the diseased gingival tissue was considered to probably be just the result of a classical nutritional deficiency in the body.
Wilkinson et al.13) gave a presentation on the use of CoQ10 for the therapy of periodontal disease.
The dentists responsible for treating periodontal disease with CoQ10 were particularly impressed with the observation that healing was -"dramatically accelerated"-and was-"very impressive".
Continued Clinical Research on Coenzyme Q10
In 1976, Wilkinson et al.14) conducted a double-blind trial with CoQ10 and a matching placebo on a group of 18 patients with periodontal disease. The trial was significantly positive (p<0 .01). Before decoding, all eight patients receiving CoQ10 and 7/10 patients receiving placebo were correctly assigned.
The remaining three patients on placebo showed mild improvement which could have been due to better hygiene. Crevicular fluid flow as a measure of response was newly monitored.
Pocket-depth, periodontal health, calculus, and the plaque score provided the data for evaluation . H6CoQ4) has been conducted by practicing dentists and periodontists with the common conclusion that CoQ is therapeutically beneficial. Six double-blind trials involving these three forms of CoQ were conducted with significant results. The trial with the "human CoQ10" was particularly significant (p<0.01).
The study of the periodontal patients which showed that 100 % had a gingival deficiency and 80 % also had a leukocytic deficiency of CoQ10 was intellectually orienting. A gingival deficiency of CoQ10 appears to predispose this tissue to periodontitis, particularly during neglected oral hygiene. It was concluded that CoQ10 can improve bioenergetics and can prophylactically and adjunctively be used for extraordinary healing during routine periodontal therapy.
In 1981, Wilkinson et al.18 ) evaluated all the chemical and physical measurements that had been and can continue to be used in evaluation of the effectiveness, or lack of it, of CoQ10 and possibly other biochemicals, to treat periodontal disease.
In 1981, Iwamoto et al. 19 ) reported on a double-blind study in Japan with 56 patients at the Hiroshima University Dental Hospital. The daily dosage of CoQ10 was 60 mg. The score of tooth mobility was significantly lower in the grcup treated with CoQ10 than in the group treated with placebo. The differences were significant at four weeks (p<0.05) and at 12 weeks (p<0.05).
The different in pocket depth was also significant at four weeks (p<0.05). It was considered that the administration of CoQ10 might cause an increase in the level of citric acid which, in turn, might favorably influence healing. It had previously been known that citric acid exerted a healing effect on the periodontal pockets in dogs subjected to an experimental trial. to patients with periodontal disease would reduce the levels of subgingival microorganisms.
They conducted two clinical trials on the oral administration of 100 mg of CoQ10 daily to 22 patients with periodontal disease for two months, and to 11 such patients for six months.
In the two-month trial, the gingival index decreased (p<0.001) and the pocket depth also decreased (p<0.001), but the plaque index did not change. Subgingival microorganisms, identified as motile rods, decreased (p<0.01) and the spirochetes also decreased (p<0.02).
In the second trial with 11 patients for six months, the gingival index was decreased (p<0.01) after both two-and six-month periods, and the pocket depth was decreased after two months (p<0.05) and six months (p<0.01), but the plaque index was unchanged after both the two-and six-month periods. Motile rods decreased after two months (p<0.01) and six months (p<0.05). The number of patients (N=11) in the six-month trial was necessarily, but unfortunately, limited.
It was concluded that this CoQ10-therapy to reduce periodontal disease, and particularly the microorganisms, is preferable to ordinary treatment with anti-bacterial agents, because CoQ10 therapy improves the immune mechanisms to control disease. The rationale for the two trials, for two months and for six months, respectively, was the existing knowledge that CoQ10 is intrinsic and indispensable to the human immune system, and that patients with periodontal disease have impaired immune systems. In the first trial with 22 patients for two months, the T4/T8 ratio was increased (p<0.001), and the CoQ10 blood level increased (p<0.001) .
In the second trial with 11 patients, which was appraised after both two and six months , the T4/T8 ratio was increased after two months (p<0.01) and after six months (p<0.05), and the IgG level was increased only after six months (p<0.05).
The CoQ10 levels were increased (p<0.001) after both the two-and six-month periods. This effective therapy with CoQ10 of periodontal disease was evident from reduced disease , an improved immune system, and restored periods of natural prevention of disease .
